02/14/2025 3:40 PM | GREAT POINT PARTNERS LLC (Filed by) Vistagen Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 12:01 PM | STEMPOINT CAPITAL LP (Filed by) Vistagen Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/13/2025 4:25 PM | Vistagen Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
02/13/2025 3:45 PM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/05/2025 4:04 PM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/14/2025 4:16 PM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/13/2025 4:39 PM | Anderson Cynthia Lynn (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2025 4:40 PM | Prince Joshua S. (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2025 4:28 PM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/06/2024 3:49 PM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 3:53 PM | Nantahala Capital Management, LLC (Filed by) Vistagen Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for VTGN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vistagen Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
09/23/2024 7:49 AM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/10/2024 4:00 PM | FitzPatrick Margaret M (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/10/2024 4:00 PM | Rotunno Mary L. (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/10/2024 4:00 PM | Cunningham Ann Michelle (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/10/2024 4:00 PM | Curley Joanne (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/10/2024 4:00 PM | GIN JERRY B (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/10/2024 4:00 PM | SAXE JON S (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/13/2024 3:49 PM | Vistagen Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024 3:53 PM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/16/2024 6:00 PM | Vistagen Therapeutics (Filer)
| Form DEF 14A | |
07/16/2024 6:04 PM | Vistagen Therapeutics (Filer)
| Form DEFA14A | |
07/12/2024 3:27 PM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/10/2024 3:34 PM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/02/2024 5:06 PM | Singh Shawn (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 5:07 PM | Adler Reid G. (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 5:08 PM | Anderson Cynthia Lynn (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 5:10 PM | Prince Joshua S. (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 4:29 PM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/26/2024 8:29 PM | Prince Joshua S. (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2024 8:30 PM | Anderson Cynthia Lynn (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2024 8:30 PM | Adler Reid G. (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2024 8:31 PM | Singh Shawn (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/25/2024 6:18 PM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/15/2024 8:52 PM | Vistagen Therapeutics (Filer)
| Form DEF 14A | |
04/05/2024 4:29 PM | Vistagen Therapeutics (Filer)
| Form PRE 14A | |
03/06/2024 5:00 PM | SAXE JON S (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 5:00 PM | Cunningham Ann Michelle (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 5:00 PM | Curley Joanne (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 5:00 PM | FitzPatrick Margaret M (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 5:00 PM | GIN JERRY B (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Watch This Robotics Demo Before March 17th (Ad) Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%...
Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… |
03/06/2024 5:00 PM | Rotunno Mary L. (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 11:15 PM | Vistagen Therapeutics (Filer)
| Form EFFECT | |